Preanalytical conditions for the measurement of plasma total homocysteine: genotype C677T MTHFR dependent non-fasting variations and anticoagulant effects on stability

被引:0
作者
Kchock, K. [1 ]
Omezzine, A. [1 ]
Rebhi, L. [1 ]
BelKahla, R. [1 ]
Belhadjmbarek, I. [1 ]
Mkhimini, A. [1 ]
Ben Rejeb, N. [1 ]
Nabli, N. [1 ]
Bouslama, A. [1 ]
机构
[1] CHU Sahloul, Biochim Lab, Sousse 4054, Tunisia
来源
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE | 2007年 / 22卷 / 05期
关键词
Homocysteine; Fasting; Anticoagulant; C677T MTHFR;
D O I
10.1016/j.immbio.2007.06.005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The pre-analytical conditions required for the measurement of plasma total homocysteine (tHcy) are poorly standardized and coercive for epidemiological studies. Our objective was an assessment of different parameters in order to simplify the pre-analytical conditions. The need for the fasting has been evaluated by the determination of fasting and post prandial tHcy: 2 h after a meat containing 1,2 g of methionin. The influence of the C677T MTHFR genotypes on postprandial tHcy variations has been studied. The possibility to transport the sample at ambient temperature has been evaluated by comparison of the tHcy values between EDTA samples conserved in ice and several anticoagulant samples (EDTA, NaF + K oxalate and EDTA + NaF + K oxatate) kept at ambient temperature (2 h and 4 h). The plasma conservation during 24 h at +4 degrees C and during 7 days at -20 degrees C has been studied. The results show significant and genotype dependent postprandial variations on tHcy determination. The use of EDTA + NaF + K oxalate as anticoagulant avoid the need for sample transport in ice. Whatever is the anticoagulant used, the conservation of plasma is possible during 24 h at +4 degrees C or 7 days at -20 degrees C is possible. (c) 2007 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:319 / 324
页数:6
相关论文
共 15 条
  • [1] HIGHER TOTAL PLASMA HOMOCYSTEINE IN VITAMIN-B12 DEFICIENCY THAN IN HETEROZYGOSITY FOR HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY
    BRATTSTROM, L
    ISRAELSSON, B
    LINDGARDE, F
    HULTBERG, B
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (02): : 175 - 178
  • [2] Stabilization of homocysteine in unseparated blood over several days: A solution for epidemiological studies
    Clark, S
    Youngman, LD
    Sullivan, J
    Peto, R
    Collins, R
    [J]. CLINICAL CHEMISTRY, 2003, 49 (03) : 518 - 520
  • [3] BIOCHEMISTRY OF SULFUR-CONTAINING AMINO-ACIDS
    COOPER, AJL
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 : 187 - 222
  • [4] Duarte NL, 2002, CLIN CHEM, V48, P665
  • [5] Ducros V, 2001, ANN BIOL CLIN-PARIS, V59, P33
  • [6] FISKERSTRAND T, 1993, CLIN CHEM, V39, P263
  • [7] A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE
    FROSST, P
    BLOM, HJ
    MILOS, R
    GOYETTE, P
    SHEPPARD, CA
    MATTHEWS, RG
    BOERS, GJH
    DENHEIJER, M
    KLUIJTMANS, LAJ
    VANDENHEUVEL, LP
    ROZEN, R
    [J]. NATURE GENETICS, 1995, 10 (01) : 111 - 113
  • [8] Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease:: Evidence for an important genetic-environmental interaction
    Girelli, D
    Friso, S
    Trabetti, E
    Olivieri, O
    Russo, C
    Pessotto, R
    Faccini, G
    Pignatti, PF
    Mazzucco, A
    Corrocher, R
    [J]. BLOOD, 1998, 91 (11) : 4158 - 4163
  • [9] Hill DM, 2002, CLIN CHEM, V48, P2017
  • [10] Ji C, 2004, WORLD J GASTROENTERO, V10, P1699